ZEB1 and gastric cancer: The detection of TAZ co-overexpression with ZEB1 and Ki67 in H. pylori-induced pre-neoplastic lesions and in invasive GC suggests that TAZ could indeed constitute a biomarker of early transformation in gastric carcinogenesis.